Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
RealAg Radio host Shaun Haney says farmers there are already sounding the alarm about what this could mean for the future of ag research.
Global pork production is expected to rise in the first half of 2026, despite trade volatility stemming from shifting import policies and swine disease pressures.
Even small declines in the calf crop translate into sustained supply pressure, supporting cattle prices over multiple years.
Clear right-to-repair guidance reduces downtime, repair costs, and operational risk.
Tennessee State Veterinarian Dr. Samantha Batey joined us with the latest on biosecurity efforts and the state’s new “Know Before You Show” initiative.
Texas Lawmakers Issue Disaster Declaration as New World Screwworm Threat Moves Closer to U.S. Border
Texas Agriculture Commissioner Sid Miller discusses the state’s latest efforts to prevent the New World screwworm from reaching Texas.
